Literature DB >> 9084652

Posttranslational modification in rat bone osteopontin.

P J Neame1, W T Butler.   

Abstract

Osteopontin is a multiply-phosphorylated glycoprotein which contains an RGD cell adhesion sequence and regions containing a high level of aspartic acid. It is abundant in bone, milk, and urine and is also found in malignant tissues. Peptides generated from rat bone osteopontin by digestion with endoprotease Lys-C were analyzed for post-translational modification by a combination of Edman degradation and matrix-assisted laser desorption mass spectrometry. In the peptides analyzed in this way (accounting for approximately half the protein), eleven sites were found that were variably phosphorylated. Three modified lysines were also detected by virtue of their inability to be cleaved by endoprotease Lys-C (Lys19 and Lys286), by observation of an anomalous pth-amino acid during Edman degradation (Lys19 Lys29 and Lys286) and by a mass difference of 115 +/- 5. Bone osteopontin is extremely heterogeneous, as none of these modifications were found in 100% of peptides examined. In this respect, bone osteopontin differs from bovine milk osteopontin in which 28 residues are completely phosphorylated (Sørensen, et al., (1995) Protein Science 4:2040-2049). While the sequences of bovine and rat osteopontin differ significantly, many conserved serines in the N- and C-terminal regions that are phosphorylated in bovine milk osteopontin are at least partially phosphorylated in the rat bone protein. However, there are also conserved residues in both bovine and rat proteins which are phosphorylated in one species but not the other.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9084652     DOI: 10.3109/03008209609029185

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  10 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  Osteopontin regulates dentin and alveolar bone development and mineralization.

Authors:  B L Foster; M Ao; C R Salmon; M B Chavez; T N Kolli; A B Tran; E Y Chu; K R Kantovitz; M Yadav; S Narisawa; J L Millán; F H Nociti; M J Somerman
Journal:  Bone       Date:  2017-12-05       Impact factor: 4.398

3.  Importance of phosphorylation for osteopontin regulation of biomineralization.

Authors:  A Gericke; C Qin; L Spevak; Y Fujimoto; W T Butler; E S Sørensen; A L Boskey
Journal:  Calcif Tissue Int       Date:  2005-07-14       Impact factor: 4.333

4.  Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications.

Authors:  Brian Christensen; Mette S Nielsen; Kim F Haselmann; Torben E Petersen; Esben S Sørensen
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  Inhibition of hydroxyapatite formation by osteopontin phosphopeptides.

Authors:  David A Pampena; Karen A Robertson; Olga Litvinova; Gilles Lajoie; Harvey A Goldberg; Graeme K Hunter
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

Review 6.  Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition.

Authors:  Anne George; Arthur Veis
Journal:  Chem Rev       Date:  2008-10-03       Impact factor: 60.622

7.  Identification of osteopontin phosphorylation sites involved in bone remodeling and inhibition of pathological calcification.

Authors:  Fawzy A Saad; Erdjan Salih; Melvin J Glimcher
Journal:  J Cell Biochem       Date:  2008-02-15       Impact factor: 4.429

8.  Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization.

Authors:  Cecilia Halling Linder; Barbro Ek-Rylander; Michael Krumpel; Maria Norgård; Sonoko Narisawa; José Luis Millán; Göran Andersson; Per Magnusson
Journal:  Calcif Tissue Int       Date:  2017-03-16       Impact factor: 4.333

9.  The role of extracellular matrix phosphorylation on energy dissipation in bone.

Authors:  Stacyann Bailey; Grazyna E Sroga; Betty Hoac; Orestis L Katsamenis; Zehai Wang; Nikolaos Bouropoulos; Marc D McKee; Esben S Sørensen; Philipp J Thurner; Deepak Vashishth
Journal:  Elife       Date:  2020-12-09       Impact factor: 8.140

10.  Osteopontin is elevated in patients with mitral annulus calcification independent from classic cardiovascular risk factors.

Authors:  Michael Sponder; Christian Reuter; Monika Fritzer-Szekeres; Brigitte Litschauer; Thomas Binder; Jeanette Strametz-Juranek
Journal:  BMC Cardiovasc Disord       Date:  2016-06-10       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.